BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31740251)

  • 1. Discovery of 1,2,4-triazine-based derivatives as novel neddylation inhibitors and anticancer activity studies against gastric cancer MGC-803 cells.
    Song J; Cui XX; Wu BW; Li D; Wang SH; Shi L; Zhu T; Zhang YB; Zhang SY
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126791. PubMed ID: 31740251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers.
    Song J; Liu Y; Yuan XY; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Fu XJ; Zhang SY
    Eur J Med Chem; 2021 Dec; 225():113801. PubMed ID: 34455358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
    Zhou H; Lu J; Yang CY; Sun Y; Wang S
    Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo.
    Fu DJ; Song J; Zhu T; Pang XJ; Wang SH; Zhang YB; Wu BW; Wang JW; Zi X; Zhang SY; Liu HM
    Eur J Med Chem; 2020 Apr; 192():112153. PubMed ID: 32135407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
    Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
    EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway.
    Song J; Gao QL; Wu BW; Zhu T; Cui XX; Jin CJ; Wang SY; Wang SH; Fu DJ; Liu HM; Zhang SY; Zhang YB; Li YC
    Eur J Med Chem; 2020 Oct; 203():112618. PubMed ID: 32682200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel indole derivatives that inhibit NEDDylation and MAPK pathways against gastric cancer MGC803 cells.
    Fu DJ; Cui XX; Zhu T; Zhang YB; Hu YY; Zhang LR; Wang SH; Zhang SY
    Bioorg Chem; 2021 Feb; 107():104634. PubMed ID: 33476867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.
    Li X; Pham V; Tippin M; Fu D; Rendon R; Song L; Uchio E; Hoang BH; Zi X
    Cell Commun Signal; 2019 Mar; 17(1):25. PubMed ID: 30885218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel benzothiazole derivatives as inhibitors of NEDDylation pathway to inhibit the progression of gastric cancer.
    Wang X; Zhao M; Chang Y; Guan S; Li M; Yang H; Sun M
    Bioorg Med Chem Lett; 2024 Mar; 100():129647. PubMed ID: 38320715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.
    Lan H; Tang Z; Jin H; Sun Y
    Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of the 2,4-disubstituted quinazoline derivative as a novel neddylation inhibitor for tumor therapy.
    Su J; Li M; Chang Y; Jia M; Zhao M; Guan S; Niu J; Zhang S; Yang H; Sun M
    Bioorg Chem; 2024 Apr; 145():107237. PubMed ID: 38442613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
    Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity.
    Fu DJ; Wang T
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):166-175. PubMed ID: 36330714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.
    Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L
    Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 5,6-diaryl-1,2,4-triazines hybrids as potential apoptosis inducers.
    Fu DJ; Song J; Hou YH; Zhao RH; Li JH; Mao RW; Yang JJ; Li P; Zi XL; Li ZH; Zhang QQ; Wang FY; Zhang SY; Zhang YB; Liu HM
    Eur J Med Chem; 2017 Sep; 138():1076-1088. PubMed ID: 28763643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
    Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
    Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NAE-dependent protein hyper-NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease.
    Lee-Law PY; Olaizola P; Caballero-Camino FJ; Izquierdo-Sanchez L; Rodrigues PM; Perugorria MJ; Azkargorta M; Elortza F; Martinez-Chantar ML; Aspichueta P; Marzioni M; Bujanda L; Drenth JPH; Banales JM
    United European Gastroenterol J; 2021 Sep; 9(7):848-859. PubMed ID: 34310849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth.
    Ni S; Chen X; Yu Q; Xu Y; Hu Z; Zhang J; Zhang W; Li B; Yang X; Mao F; Huang J; Sun Y; Li J; Jia L
    Eur J Med Chem; 2020 Jan; 185():111848. PubMed ID: 31732254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma.
    Tong S; Si Y; Yu H; Zhang L; Xie P; Jiang W
    Sci Rep; 2017 Jul; 7(1):5599. PubMed ID: 28717191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overactivated neddylation pathway as a therapeutic target in lung cancer.
    Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
    J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.